IVF Stock Analysis: Buy, Sell, or Hold?
IVF - INVO Fertility, Inc. Common Stock
$1.06
-0.09 (-7.83%)
âŧ
5d:
+9.1%
30d:
+3.92%
90d:
-32.91%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When IVF Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: IVF is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: IVF is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: IVF is currently trading at $1.06, which is considered slightly high relative to its 30-day fair value range of $0.93 to $1.20.
Technical Outlook: Technically, IVF is in a strong downtrend. Immediate support is located at $0.95, while resistance sits at $2.80. Short-term momentum is weak, with the stock down 7.8% recently.
Market Sentiment: IVF scores 34/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $20.00 (+1786.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, IVF is in a strong downtrend. Immediate support is located at $0.95, while resistance sits at $2.80. Short-term momentum is weak, with the stock down 7.8% recently.
Market Sentiment: IVF scores 34/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $20.00 (+1786.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$0.93 -
$1.20
Company Quality Score
38/100
(SELL)
Volume Confirmation
MODERATE
Confidence Score
31.6%
All Signals
- BEARISH: Weak technical setup (34/100)
- BEARISH: Downward momentum (-7.8%)
- BULLISH: Trading 1786.8% below Wall St target ($20.00)
- WARNING: Composite score 38/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.93 -
$1.20
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$0.95
Resistance Level
$2.80
Current Trend
Strong Downtrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.13
Wall Street Target
$20.00
(+1786.8%)
Revenue Growth (YoY)
16.7%
Profit Margin
-70.2%
Share & Embed Analysis
Last updated: August 23, 2026 7:50 AM ET
Data refreshes hourly during market hours. Next update: 8:50 AM
Data refreshes hourly during market hours. Next update: 8:50 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IVF showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$63 | 49 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 53 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 48 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 49 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 35 SELL |